Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-05-11 @ 3:12 PM
Study NCT ID:
NCT07260305
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2025-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
Sponsor:
Kangabio AUSTRALIA LTD PTY
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KGX101ST102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None